Literature DB >> 21320699

Adherence and persistence with taking medication to control high blood pressure.

Martha N Hill1, Nancy Houston Miller, Sabina Degeest, Barry J Materson, Henry R Black, Joseph L Izzo, Suzanne Oparil, Michael A Weber.   

Abstract

Nonadherence and poor or no persistence with taking antihypertensive medications results in uncontrolled high blood pressure, poor clinical outcomes and preventable health care costs. Factors associated with nonadherence are multilevel and relate not only to the patient, but also to the provider, health care system, health care organization, and community. National guideline committees have called for more aggressive approaches to implement strategies known to improve adherence and technologies known to enable changes at the systems level including improved communication among providers and patients. Improvements in adherence and persistence are likely to be achieved by supporting patient self-management, a team approach to patient care, technology-supported office practice systems, better methods to measure adherence, and less clinical inertia. Integrating high blood pressure control into health care policies that emphasize and improve prevention and management of chronic illness remains a challenge. Four strategies are proposed: focusing on clinical outcomes; empowering informed, activated patients; developing prepared proactive practice teams; and advocating for health care policy reform. With hypertension remaining the most common reason for office visits, the time is now.
Copyright © 2011 Wiley Periodicals, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21320699     DOI: 10.1016/j.jash.2011.01.001

Source DB:  PubMed          Journal:  J Am Soc Hypertens        ISSN: 1878-7436


  31 in total

Review 1.  Should two-drug initial therapy for hypertension be recommended for all patients?

Authors:  Jennifer B Cowart; Addison A Taylor
Journal:  Curr Hypertens Rep       Date:  2012-08       Impact factor: 5.369

2.  Provider views about responsibility for medication adherence and content of physician-older patient discussions.

Authors:  Derjung M Tarn; Thomas J Mattimore; Douglas S Bell; Richard L Kravitz; Neil S Wenger
Journal:  J Am Geriatr Soc       Date:  2012-05-30       Impact factor: 5.562

3.  Reducing clinical inertia in hypertension treatment: a pragmatic randomized controlled trial.

Authors:  Amy G Huebschmann; Trina Mizrahi; Alyssa Soenksen; Brenda L Beaty; Thomas D Denberg
Journal:  J Clin Hypertens (Greenwich)       Date:  2012-03-16       Impact factor: 3.738

Review 4.  Adherence to antihypertensive therapy and therapeutic dosage of antihypertensive drugs.

Authors:  Franco Rabbia; Chiara Fulcheri; Silvia Di Monaco; Michele Covella; Elisa Perlo; Marco Pappaccogli; Franco Veglio
Journal:  High Blood Press Cardiovasc Prev       Date:  2016-05-09

Review 5.  Molecular sources of residual cardiovascular risk, clinical signals, and innovative solutions: relationship with subclinical disease, undertreatment, and poor adherence: implications of new evidence upon optimizing cardiovascular patient outcomes.

Authors:  Richard Kones
Journal:  Vasc Health Risk Manag       Date:  2013-10-21

6.  Optimal medical therapy is vital for patients with coronary artery disease and acute coronary syndromes regardless of revascularization strategy.

Authors:  Javaid Iqbal; Patrick W Serruys
Journal:  Ann Transl Med       Date:  2017-03

7.  Medication adherence and beyond: Blood pressure control and the pharmacist.

Authors:  Ann Thompson; William Semchuk
Journal:  Can Pharm J (Ott)       Date:  2012-03

Review 8.  Treatment strategies for resistant arterial hypertension.

Authors:  Felix Mahfoud; Frank Himmel; Christian Ukena; Heribert Schunkert; Michael Böhm; Joachim Weil
Journal:  Dtsch Arztebl Int       Date:  2011-10-28       Impact factor: 5.594

9.  Association of Perceived Stress and Discrimination on Medication Adherence among Diverse Patients with Uncontrolled Hypertension.

Authors:  Carmen Alvarez; Anika L Hines; Kathryn A Carson; Nadia Andrade; Chidinma A Ibe; Jill A Marsteller; Lisa A Cooper
Journal:  Ethn Dis       Date:  2021-01-21       Impact factor: 1.847

Review 10.  Medication adherence and resistant hypertension.

Authors:  D J Hyman; V Pavlik
Journal:  J Hum Hypertens       Date:  2014-09-11       Impact factor: 3.012

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.